Ironwood Pharmaceuticals Shares Outstanding 2009-2020 | IRWD

Ironwood Pharmaceuticals shares outstanding from 2009 to 2020. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Ironwood Pharmaceuticals Annual Shares Outstanding
(Millions of Shares)
2020 161
2019 156
2018 153
2017 149
2016 145
2015 142
2014 137
2013 116
2012 106
2011 100
2010 90
2009 7
2008 7
2007 7
2006 6
Ironwood Pharmaceuticals Quarterly Shares Outstanding
(Millions of Shares)
2020-12-31 161
2020-09-30 160
2020-06-30 160
2020-03-31 160
2019-12-31 156
2019-09-30 157
2019-06-30 156
2019-03-31 155
2018-12-31 153
2018-09-30 153
2018-06-30 152
2018-03-31 151
2017-12-31 149
2017-09-30 150
2017-06-30 149
2017-03-31 148
2016-12-31 145
2016-09-30 145
2016-06-30 145
2016-03-31 144
2015-12-31 142
2015-09-30 142
2015-06-30 142
2015-03-31 141
2014-12-31 137
2014-09-30 139
2014-06-30 138
2014-03-31 130
2013-12-31 116
2013-09-30 121
2013-06-30 113
2013-03-31 108
2012-12-31 106
2012-09-30 114
2012-06-30 107
2012-03-31 104
2011-12-31 100
2011-09-30 100
2011-06-30 100
2011-03-31 99
2010-12-31 90
2010-09-30 98
2010-06-30 98
2010-03-31 64
2009-12-31 7
2009-09-30 7
2009-06-30 7
2009-03-31 7
2008-12-31
2008-09-30
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $1.489B $0.390B
Ironwood Pharmaceuticals is an entrepreneurial pharmaceutical company that discovers, develops, and intends to commercialize innovative human medicines. The Company's first in class compound, Linaclotide, is being evaluated in a confirmatory Phase 3 program for the treatment of irritable bowel syndrome with constipation and chronic constipation. The Company also focuses on one Phase 1 pain drug candidate and multiple preclinical programs, as well as on building a specialty biochemicals business based on a proprietary strain-development platform. Ironwood also has a growing pipeline of additional drug candidates in earlier stages of development. Ironwood is headquartered in Cambridge, Massachusetts.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $75.575B 41.31
Takeda Pharmaceutical (TAK) Japan $54.290B 9.95
Astellas Pharma (ALPMY) Japan $31.334B 19.34
Eisai (ESALY) Japan $21.596B 23.95
Catalent (CTLT) United States $19.602B 51.87
Grifols, S.A (GRFS) Spain $10.808B 12.38
Neurocrine Biosciences (NBIX) United States $10.391B 24.10
Jazz Pharmaceuticals (JAZZ) Ireland $9.772B 16.32
Arrowhead Pharmaceuticals (ARWR) United States $8.825B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $8.421B 0.00
Ionis Pharmaceuticals (IONS) United States $7.859B 0.00
United Therapeutics (UTHR) United States $7.719B 15.03
IPSEN SA ADR (IPSEY) France $7.134B 0.00
Evotec AG (EVTCY) Germany $6.324B 427.08
Orion OYJ (ORINY) Finland $5.794B 20.11
FibroGen (FGEN) United States $4.824B 0.00
ChemoCentryx (CCXI) United States $4.677B 0.00
Sage Therapeutics (SAGE) United States $4.426B 0.00
Cronos Group (CRON) Canada $4.111B 0.00
Nektar Therapeutics (NKTR) United States $4.085B 0.00
Hypermarcas (HYPMY) Brazil $3.941B 15.56
PTC Therapeutics (PTCT) United States $3.932B 0.00
Tilray (TLRY) Canada $3.736B 0.00
Pacira BioSciences (PCRX) United States $3.424B 74.36
Revolution Medicines (RVMD) United States $3.145B 0.00
Corcept Therapeutics (CORT) United States $3.121B 31.30
Xencor (XNCR) United States $2.787B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.784B 17.25
AlloVir (ALVR) United States $2.693B 0.00
Endo (ENDP) Ireland $2.273B 3.45
Sundial Growers (SNDL) Canada $2.264B 0.00
BioCryst Pharmaceuticals (BCRX) United States $2.085B 0.00
USANA Health Sciences (USNA) United States $1.973B 16.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.856B 0.00
ImmunoGen (IMGN) United States $1.778B 0.00
Heron Therapeutics (HRTX) United States $1.754B 0.00
Translate Bio (TBIO) United States $1.674B 0.00
Organogenesis Holdings (ORGO) United States $1.573B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.529B 10.63
Ocular Therapeutix (OCUL) United States $1.355B 0.00
Indivior (INVVY) United States $1.329B 0.00
Zogenix (ZGNX) United States $1.304B 0.00
Trillium Therapeutics (TRIL) Canada $1.264B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.119B 0.00
Karyopharm Therapeutics (KPTI) United States $1.089B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.043B 0.00
CLINIGEN GP (CLIGF) United Kingdom $0.942B 0.00
Radius Health (RDUS) United States $0.922B 0.00
Collegium Pharmaceutical (COLL) United States $0.903B 53.26
Aclaris Therapeutics (ACRS) United States $0.887B 0.00
Vectura Group (VEGPF) United Kingdom $0.877B 0.00
VAXART, INC (VXRT) United States $0.804B 0.00
Esperion Therapeutics (ESPR) United States $0.796B 0.00
Aerie Pharmaceuticals (AERI) United States $0.766B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.738B 0.00
Chinook Therapeutics (KDNY) United States $0.695B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.692B 0.00
Altimmune (ALT) United States $0.648B 0.00
KalVista Pharmaceuticals (KALV) United States $0.622B 0.00
Summit Therapeutics (SMMT) United States $0.619B 0.00
Akebia Therapeutics (AKBA) United States $0.619B 0.00
Ardelyx (ARDX) United States $0.616B 0.00
Acutus Medical (AFIB) United States $0.601B 0.00
Rafael Holdings (RFL) United States $0.591B 0.00
Molecular Templates (MTEM) United States $0.578B 0.00
Flexion Therapeutics (FLXN) United States $0.552B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.546B 0.00
AVITA Medical (RCEL) United States $0.543B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.516B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.504B 0.00
Siga Technologies (SIGA) United States $0.503B 14.13
TherapeuticsMD (TXMD) United States $0.489B 0.00
DURECT (DRRX) United States $0.475B 0.00
PROFOUND MEDICL (PROF) Canada $0.469B 0.00
Harpoon Therapeutics (HARP) United States $0.464B 0.00
Jounce Therapeutics (JNCE) United States $0.439B 0.00
MEI Pharma (MEIP) United States $0.437B 0.00
VYNE Therapeutics (VYNE) United States $0.431B 0.00
Redhill Biopharma (RDHL) Israel $0.425B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.418B 10.89
Innate Pharma SA (IPHYF) France $0.350B 0.00
Nature's Sunshine Products (NATR) United States $0.339B 21.86
CASI Pharmaceuticals (CASI) United States $0.328B 0.00
Onconova Therapeutics (ONTX) United States $0.318B 0.00
Xeris Pharmaceuticals (XERS) United States $0.286B 0.00
Oncternal Therapeutics (ONCT) United States $0.284B 0.00
Jaguar Animal Health (JAGX) United States $0.280B 0.00
Alpine Immune Sciences (ALPN) United States $0.274B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.273B 0.00
Lannett Co Inc (LCI) United States $0.252B 8.46
Novan (NOVN) United States $0.249B 0.00
CTI BioPharma (CTIC) United States $0.240B 0.00
IMV INC (IMV) Canada $0.238B 0.00
Iterum Therapeutics (ITRM) Ireland $0.230B 0.00
Ayala Pharmaceuticals (AYLA) Israel $0.220B 0.00
Infinity Pharmaceuticals (INFI) United States $0.219B 0.00
Qilian Holding Group (QLI) China $0.215B 0.00
OptiNose (OPTN) United States $0.215B 0.00
Taiwan Liposome (TLC) Taiwan $0.210B 0.00
Calithera Biosciences (CALA) United States $0.210B 0.00
Concert Pharmaceuticals (CNCE) United States $0.210B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.208B 0.00
Heat Biologics (HTBX) United States $0.193B 0.00
IsoRay (ISR) United States $0.192B 0.00
Nutriband (NTRB) United States $0.191B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.188B 0.00
Aquestive Therapeutics (AQST) United States $0.184B 0.00
KemPharm (KMPH) United States $0.179B 0.00
Genocea Biosciences (GNCA) United States $0.170B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.166B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.164B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.159B 0.00
Aziyo Biologics (AZYO) United States $0.157B 0.00
Champions Oncology (CSBR) United States $0.156B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.153B 0.00
MediWound (MDWD) Israel $0.152B 0.00
Otonomy (OTIC) United States $0.142B 0.00
Lipocine (LPCN) United States $0.135B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.125B 0.00
ProPhase Labs (PRPH) United States $0.124B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.119B 0.00
Recro Pharma (REPH) United States $0.119B 0.00
Assertio Holdings (ASRT) United States $0.110B 0.00
ElectroCore (ECOR) United States $0.109B 0.00
Baudax Bio (BXRX) United States $0.105B 0.00
Natural Alternatives (NAII) United States $0.105B 28.50
Entasis Therapeutics Holdings (ETTX) United States $0.103B 0.00
AIM ImmunoTech (AIM) United States $0.096B 0.00
SCYNEXIS (SCYX) United States $0.091B 0.00
India Globalization Capital (IGC) United States $0.087B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.085B 0.00
AgeX Therapeutics (AGE) United States $0.085B 0.00
PolarityTE (PTE) United States $0.082B 0.00
Biomerica (BMRA) United States $0.076B 0.00
CV Sciences (CVSI) United States $0.075B 0.00
Inhibikase Therapeutics (IKT) United States $0.073B 0.00
Sigyn Therapeutics (SIGY) United States $0.073B 0.00
Brickell Biotech (BBI) United States $0.071B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.068B 0.00
Addex Therapeutics (ADXN) Switzerland $0.064B 0.00
Trimel Pharmaceuticals (ASPCF) Canada $0.060B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.057B 0.00
Regulus Therapeutics (RGLS) United States $0.054B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.052B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.051B 26.00
Salarius Pharmaceuticals (SLRX) United States $0.051B 0.00
Neos Therapeutics (NEOS) United States $0.048B 0.00
RXi Pharmaceuticals (PHIO) United States $0.046B 0.00
Mannatech (MTEX) United States $0.037B 5.46
Can-Fite Biopharma (CANF) Israel $0.036B 0.00
Midatech Pharma (MTP) United Kingdom $0.032B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.029B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.025B 0.00
Cyanotech (CYAN) United States $0.023B 19.20
HANCOCK JAFFE (HJLI) United States $0.020B 0.00
China SXT Pharmaceuticals (SXTC) China $0.020B 0.00
JanOne (JAN) United States $0.020B 0.00
Xenetic Biosciences (XBIO) United States $0.018B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.018B 0.00
Plus Therapeutics (PSTV) United States $0.015B 0.00
SHINECO INC (TYHT) China $0.015B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00